MedinCell S.A. Profile Avatar - Palmy Investing

MedinCell S.A.

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceuti…

Biotechnology
FR, Jacou [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

MedinCell S.A. can't present it's latest revenue by geo. area

Revenue By Geographic Areas

MedinCell S.A. can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

MedinCell S.A. can't present revenue by segment

Historical Revenue By Geographic Area

Last 3Y, in mil. USD

MedinCell S.A. can't present revenue by geo. area

End of MEDCL.PA's Analysis
CIK: - CUSIP: F6104D107 ISIN: FR0004065605 LEI: - UEI: -
Secondary Listings
MEDCL.PA has no secondary listings inside our databases.